Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Teva
US Army
Argus Health
US Department of Justice
Julphar
Express Scripts
Harvard Business School
Merck
Johnson and Johnson

Generated: February 21, 2018

DrugPatentWatch Database Preview

KETALAR Drug Profile

« Back to Dashboard

When do Ketalar patents expire, and what generic alternatives are available?

Ketalar is a drug marketed by Par Sterile Products and is included in one NDA.

The generic ingredient in KETALAR is ketamine hydrochloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.
Drug patent expirations by year for KETALAR
Pharmacology for KETALAR
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for KETALAR

US Patents and Regulatory Information for KETALAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products KETALAR ketamine hydrochloride INJECTABLE;INJECTION 016812-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products KETALAR ketamine hydrochloride INJECTABLE;INJECTION 016812-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products KETALAR ketamine hydrochloride INJECTABLE;INJECTION 016812-003 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Julphar
Cipla
Federal Trade Commission
Harvard Business School
Johnson and Johnson
Cerilliant
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot